Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back


Chris D. Geddes

Director of the Institute of Fluorescence, USA

Biography

Dr Chris D. Geddes, Ph.D., FRSC, Professor, has extensive experience in fl uorescence spectroscopy, particularly in fl uorescence sensing and metal-fl uorophore
interactions, publishing over 275 peer-reviewed papers (h-index: 45), and 30 books. Dr Geddes is internationally known in fl uorescence and plasmonics and
his laboratory is widely attributed to the development of the Metal-Enhanced Fluorescence (MEF) and related plasmon-fl uorescence technologies, securing in
excess of $25 million in recent years to pursue his research aspirations. He is the editor-in-chief of the Journal of Fluorescence and founding editor-in-chief of the
Who’s Who in Fluorescence, Annual Reviews in Fluorescence and the Annual Reviews in Plasmonics volumes. In addition, due to the labs’ pioneering efforts in
the fi elds of metallic nanoparticle-fl uorophore interactions, Dr Geddes launched a Springer Journal "Plasmonics" in 2005, which is a leading journal in the fi eld
today. Dr Geddes is Director of the Institute of Fluorescence, a department within UMBC (University of Maryland Baltimore County), which focuses on the nanobio-
technological applications of fl uorescence. Dr Geddes has been a permanent member of the NIH’s EBIT R01 study section (2007-2012) and chaired the NIH’s
Analytical and BioAnalytical SBIR study section from ~ 2004-2009. Dr Geddes is a fellow of both the Royal Society of Chemistry (FRSC) and the Institute of Physics.
Dr Geddes holds > 100 patents in the fi elds of fl uorescence and plasmonics and his roles and interactions with industry have created enterprise value in excess
of $100 Million dollars.

Abstract

Abstract : Lyse-It - A rapid 30 second transformational lysing and DNA fragmentation technology